Immatics NV (IMTX)
10.53
-0.10
(-0.94%)
USD |
NASDAQ |
May 22, 10:48
Immatics Total Assets (Quarterly): 705.31M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 705.31M |
December 31, 2023 | 563.72M |
September 30, 2023 | 463.04M |
June 30, 2023 | 445.77M |
March 31, 2023 | 412.72M |
December 31, 2022 | 437.35M |
September 30, 2022 | 348.23M |
June 30, 2022 | 384.72M |
March 31, 2022 | 314.95M |
Date | Value |
---|---|
December 31, 2021 | 197.74M |
September 30, 2021 | 230.72M |
June 30, 2021 | 257.65M |
March 31, 2021 | 278.74M |
December 31, 2020 | 313.20M |
September 30, 2020 | 332.30M |
June 30, 2020 | 121.39M |
December 31, 2019 | 150.41M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
121.39M
Minimum
Jun 2020
705.31M
Maximum
Mar 2024
350.47M
Average
332.30M
Median
Sep 2020
Total Assets (Quarterly) Benchmarks
MorphoSys AG | 2.240B |
Affimed NV | 107.40M |
InflaRx NV | 115.65M |
BioNTech SE | 24.04B |
CureVac NV | 871.33M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 272.50M |
Shareholders Equity (Quarterly) | 432.81M |
Current Ratio | 3.946 |